Research fest

Academics like to discuss paper rejections and gatekeeping. The other end of this spectrum is highlighting research that deserves our attention.

Let’s promote good research: Share it in accessible and engaging ways. Put it in context and help your colleagues appreciate it. The more we can put substance ahead of hype, the more science and our colleagues benefit from our highlights.

Below are links to tweets of papers that I find interesting and worth sharing!

Premature human engineering

The news buzz alive with excitement about human genome editing, even human germline engineering. Successful germline engineering requires (1) a technology for editing DNA safely and (2) knowledge of what to edit and how to edit based on understanding the underlying biology. We are approaching (1), which is the easier part; we do not have (2), and we are far from achieving it for most desired “edits”.

A huge hurdle to germline engineering is that, beyond a few simple cases, our understanding does not allow achieving desired effects while avoiding unintended consequences. Unlike DNA sequencing, silicon chips and DNA editing, our understanding of complex combinatorial multi-gene interactions has made very little progress over the last few decades. Until we made more progress and understand gene interactions and the respective health outcomes better, germline engineering is akin to medieval quack therapies based the technology to bleed patients and feed them various concoctions but with very limited understanding of the medical consequences, and with plenty of unintended consequences. We can fix the unintended consequences later and then fix the unintended consequences from the fixing, and we will keep trying!

Increasingly direct evidence

The results in our Cell report are particularly satisfying to me since they bring clarity to a puzzle that I have pursued for almost a decade. The puzzle started with an observation that I made while a graduate student in the Botstein laboratory at Princeton University.

As growth rate increases, RPs are transcriptionally induced to varying degrees; some are even repressed.

I studied the transcriptional responses of yeast cells growing across a wide range of growth rates. These data allowed us to evaluate a suggestion that Ole Maaløe had proposed for bacteria over 30 years earlier: cells growing faster should induce the transcription of ribosomal proteins since they need to make more ribosomes that can meet the increased demands for protein synthesis. While most mRNAs coding for ribosomal proteins (RPs) exhibited this logical trend (their levels increased with the growth rate), others did not. The RP transcript levels that deviated from the expectation were reproducible across biological replicas and even across different nutrient limitations used to control the cell growth rate. Furthermore, the number of the RP transcripts defying the expectations was even larger when I grew the yeast cells on ethanol carbon source. I also observed uncorrelated variability in RP transcripts across human cancers, but this observation was based on public data without biological replicates and with many confounding factors.

My observations of differential RP transcriptional induction puzzled me deeply. According to the decades-old model of the ribosomes, each ribosome has exactly one copy of each core RP. Thus, the simplest mechanism for making more ribosomes is to induce the transcription of each RP by the same amount, not to induce some RPs and repress others. Still, biology often defies simplistic expectations; one can easily imagine that RP levels are controlled mostly post-transcriptionally. Transcript levels for RPs were enough to pick my curiosity but ultimately too indirect to serve as evidence for the protein composition of the ribosomes. Thus, I neglected the large differences in RP transcriptional responses and interpreted our data with the satisfyingly simple framework suggested by Ole Maaløe. Many other research groups have also reported differential transcription of RP genes but these observations have the same limitations as my transcriptional data.  The puzzle remained latent in my mind until years later I quantified the yeast proteome by mass-spectrometry as part of investigating trade-offs of aerobic glycolysis. This time, the clue for altered protein composition of the ribosomes was at the level of the ribosomal proteins, not their transcripts. While still indirect and inconclusive, I found this observation compelling. It motivated me to design experiments specifically aiming to find out if the protein composition of the ribosome can vary within a cell and across growth conditions.

The data from these experiments showed that unperturbed cells build ribosomes with different protein compositions that depend both on the number of ribosomes bound per mRNA and on the growth conditions. I find this an exciting result because it opens the door to conceptual questions such as: What is the extent, scope and specificity of ribosome-mediated translational regulation? What are the advantages of regulating gene expression by modulating the ribosomal composition as compared to the other layers of gene regulation, from histone modifications through RNA processing to protein degradation? Do altered ribosomal compositions offer tradeoffs, such as higher translational accuracy at the expense of lower translation-elongation rate via more kinetic proofreading? Some of these question may (hopefully will) reveal general principles. These questions are fascinating to speculate about but they can also be answered by direct measurements. Designing experiments that can rigorously explore and discriminate among different conceptual models should be a lot of fun!


CSHL Translational Control Meeting 2016